Rheumatoid arthritis: vizsgálatok itt: Hollandia
26 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 15.. Ask the study team whether a trial fits you.
- 1. fázisTaking peopleA Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
- Where
- Amsterdam
- Életkor
- 18 év to 70 év
- People
- 72 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06916806 · EU 2024-519015-34-00 - 1. fázisNot yet taking people in HollandiaA Study of BMS-986553 in Participants With Refractory Autoimmune Diseases
- Where
- Amsterdam, Leiden
- Életkor
- 18 év and over
- People
- 60 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07873931 - 2. fázisTaking people[18F]PEG-folate PET-CT imaging for monitoring of therapy response in Rheumatoid Arthritis patients
- Where
- Amsterdam, Groningen
- Életkor
- 18 év and over
- People
- 20
- Run by
- Amsterdam UMC Stichting
See details and how to join2024-513537-21-02 - 4. fázisNot yet taking people in HollandiaTapering optimisation with placebo-based mechanisms in rheumatoid arthritis: the TOP-RA trial
- Where
- Enschede, Hoorn Nh, Leeuwarden, Leiden, Rotterdam, 's-Gravenhage, Venlo
- Életkor
- 18 év and over
- People
- 231
- Run by
- Universiteit Leiden
See details and how to join2025-524593-42-00 - 2. fázisNot yet taking people in HollandiaA study to assess the safety and efficacy of different doses of ELV001 to treat active rheumatoid arthritis in patients with an inadequate response to methotrexate and tumor necrosis factor inhibition (START SYNERGY)
- Where
- Amsterdam, Maastricht, Rotterdam
- Életkor
- 18 év and over
- People
- 95 worldwide
- Run by
- Elevara Medicines Limited
See details and how to join2025-524005-32-00 - 4. fázisBefejeződött3TR-PARTNER-RA
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 182 worldwide
- Run by
- Queen Mary University Of London
See details and how to join2024-511470-79-00 - 4. fázisTaking peopleDiscontinuation of Disease-modifying Anti-rheumatic Drugs (DMARDs) in Rheumatoid Arthritis Patients Also Using TNF Inhibitors
- Where
- Amsterdam, Rotterdam, Tilburg, Ubbergen
- Életkor
- 18 év and over
- People
- 202
- Run by
- Sint Maartenskliniek
See details and how to joinNCT07802678 · EU 2026-525316-33-00 - 1. fázisBefejeződöttA Study to Evaluate Targeted Therapies for Patients with Rheumatoid Arthritis
- Where
- Amsterdam, Leiden
- Életkor
- 18 év and over
- People
- 19 worldwide
- Run by
- AbbVie Deutschland GmbH & Co. KG
See details and how to join2025-523127-21-00 - 1. fázisTaking peopleA Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA)
- Where
- Amsterdam, Utrecht
- Életkor
- 18 év to 75 év
- People
- 36 worldwide
- Run by
- AbbVie
See details and how to joinNCT06977724 · EU 2024-519157-10-00 - 4. fázisNot yet taking people in HollandiaThe 3TR Molecular Pathobiology-Driven Precision Therapy in RA (3TR Precis-The-RA) study
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 197 worldwide
- Run by
- Queen Mary University Of London
See details and how to join2022-502021-18-00 - 2. fázisTaking peopleImaging of inflamed arteries in giant cell arteritis and inflamed joints in rheumatoid arthritis with a PET/CT scan.
- Where
- Amsterdam, Groningen
- Életkor
- 18 év and over
- People
- 20
- Run by
- Universitair Medisch Centrum Groningen
See details and how to join2024-514489-38-01 - No phaseFut, nem toborozClinical Outcomes Study of the Nexel Total Elbow
- Where
- Breda
- Életkor
- 18 év and over
- People
- 134 worldwide
- Run by
- Zimmer Biomet
See details and how to joinNCT02469662 - 1. fázisTaking peopleA placebo-controlled, single-blind, phase I study in healthy volunteers and patients with Rheumatoid Arthritis with ABO21009
- Where
- Leiden
- Életkor
- 18 év and over
- People
- 78 worldwide
- Run by
- Aboleris Holdco
See details and how to join2024-517547-31-00 - 1. fázisNot yet taking people in HollandiaA phase Ib, open-label, ascending dose study to assess safety, tolerability and pharmacokinetics of PIT565 in participants with rheumatoid arthritis (RA)
- Where
- Leiden
- Életkor
- 18 év and over
- People
- 40 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2024-520196-27-00 - 4. fázisTaking peopleMethMax trial
- Where
- Leiden
- Életkor
- 18 év and over
- People
- 212 worldwide
- Run by
- Medical University of Vienna
See details and how to join2023-507714-27-00 - 4. fázisTaking peopleREDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases
- Where
- Amsterdam, Enschede, Harderwijk, Maastricht, Nijmegen, Rotterdam, Tilburg, Ubbergen, Uden, Zwolle
- Életkor
- 16 év and over
- People
- 200
- Run by
- Sint Maartenskliniek
See details and how to joinNCT07160231 · EU 2025-520757-36-00 - 2. fázisTaking peopleFluorescence Imaging of IBD and RA Using Adalimumab-800CW
- Where
- Groningen
- Életkor
- 18 év and over
- People
- 36
- Run by
- University Medical Center Groningen
See details and how to joinNCT03938701 · EU 2024-513390-50-00 - 4. fázisTaking peopleBetter After CHoosing. Randomly Allocated or Patient Preference Based Treatment With Filgotinib or TNFi in RA (BACH)
- Where
- Leeuwarden
- Életkor
- 18 év to 101 év
- People
- 100
- Run by
- R.Bos
See details and how to joinNCT04985435 - 4. fázisNot yet taking people in HollandiaInvestigating the (autoreactive) B cell compartment in antibody-mediated autoimmune diseases in comparison with the recall Tetanus Toxoid response
- Where
- Leiden
- Életkor
- 18 év and over
- People
- 96
- Run by
- Leids Universitair Medisch Centrum (LUMC)
See details and how to join2024-515312-50-00 - 4. fázisNot yet taking people in HollandiaFilgotinib bridging in newly diagnosed rheumatoid arthritis patients (FAST RA trial); A pragmatic randomized controlled non-inferiority low intervention clinical trial
- Where
- Enschede
- Életkor
- 18 év to 64 év
- People
- 168
- Run by
- Medisch Spectrum Twente
See details and how to join2024-517112-30-00 - 4. fázisTaking peopleTocilizumab Dose Optimization in Rheumatoid Arthritis
- Where
- Alkmaar, Amsterdam, Rotterdam, Ubbergen
- Életkor
- 18 év and over
- People
- 98
- Run by
- Reade revalidatie & reumatologie centrum te Amsterdam
See details and how to join2025-520513-30-00 - No phaseCsak meghívásosEMDR for Persistent Pain in RA
- Where
- Enschede
- Életkor
- 18 év and over
- People
- 10
- Run by
- Medisch Spectrum Twente
See details and how to joinNCT05941559 - 4. fázisTaking peopleComparing the effectiveness of tofacitinib extended release (XR) chronotherapy, morning versus evening dosing, in rheumatoid arthritis (RA) and psoriatic arthritis (PsA) patients from a patient's, clinical as well as a translational point of view.
- Where
- Capelle aan den IJssel, Rotterdam
- Életkor
- 18 év and over
- People
- 84
- Run by
- Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
See details and how to join2024-517865-17-01 - No phaseTaking peopleConsideRAte Study - Splenic Stimulation for RA
- Where
- Amsterdam, Eindhoven
- Életkor
- 22 év to 75 év
- People
- 28 worldwide
- Run by
- Galvani Bioelectronics
See details and how to joinNCT05003310 - No phaseTaking peopleSafety of Splenic Stimulation for RA
- Where
- Amsterdam
- Életkor
- 22 év to 75 év
- People
- 5 worldwide
- Run by
- Galvani Bioelectronics
See details and how to joinNCT04955899